Anaemia in Heart Failure Patients, Associated with Angiotensin - Renin - Aldosterone System Altering Medications.

Autor: Jonaitienė, Neda¹ neda.dauksaite@gmail.com, Ramantauskaitė, Grytė¹, Laukaitienė, Jolanta¹

Publikováno v: Heart Views. Jul-Sep2021, Vol. 22 Issue 3, p196-200. 5p.

Impact of angiotensin receptor-neprilysin inhibitor on echocardiographic parameters and quality of life in heart failure patients with reduced ejection fraction

Autor: Jonaitienė, Neda, Ramantauskaitė, Grytė, Laukaitienė, Jolanta

Publikováno v: International Congress Brain, Heart & Kidney 2020 : abstract book : October 22-24, 2020, Vilnius, Lithuania / Lithuanian Neurologists Association, Vilnius : Lithuanian Neurologists Association, 2020, p. 61

Introduction: Heart failure (HF) is a progressive clinical syndrome affecting >38 million people globally1. A new class of agents for treating chronic HF has been developed, known as angiotensin receptor neprilysin inhibitors (ARNI)2-4. ARNI enhances

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2888::7315f858cea3f43cc87cc1914807c19b
https://library.lsmuni.lt/LSMU:ELABAPDB77678225&prefLang=en_US